Reducing MARVELD1 levels in lung cancer tissues also reduces the efficiency of NMD by diminishing the link between the UPF1/SMG1 components of the NMD complex and the mRNA containing a premature stop codon (PTC-mRNA) 18, 34. This evidence concerns the gene MARVELD1 and lung cancer.